Nearly five years after the signing of the contract, the cooperation between Wantai Biotech and the global vaccine giant GlaxoSmithKline on the nine-valent vaccine finally ended in a "breakup". For Wantai Biotech, with the bivalent vaccine making money...
07-23
How to see the continued pullback in the first quarter? Gülen, Zhao Bei and other celebrities revealed the latest layout ideas of medicine and biology, Finance Associated Press, March 31 (Reporter Zhou Xiaoya) In the first quarter of this year, the overall performance of the market...
03-31